Efficacy and safety of abrocitinib in patients with moderate‐to‐severe atopic dermatitis with prior exposure to oral systemic immunosuppressants or biologic therapies: A post hoc analysis of the JADE clinical trials

• मुख्य लेखकों: Melinda J. Gooderham (लेखक), Michael R. Ardern‐Jones (लेखक), Emma Guttman‐Yassky (लेखक), Mahreen Ameen (लेखक), Eric L. Simpson (लेखक), Gary Chan (लेखक), Pinaki Biswas (लेखक), Wing S. Chiu (लेखक), Melissa Watkins (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Wiley, 2023-12-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Abstract Background Patients with moderate‐to‐severe atopic dermatitis (AD) refractory to topical therapy might require treatment with systemic therapies, including biologics. Objectives To assess the efficacy and safety of abrocitinib monotherapy in patients who previously received systemic therapi...